论文部分内容阅读
目的:分析探讨丹参川芎嗪注射液联合脑苷肌肽治疗急性缺血性脑卒中的临床治疗效果。方法:60例急性缺血性脑卒中住院患者,随机分为对照组和观察组,每组30例,分别应用常规治疗加脑苷肌肽注射液和在对照组用药基础上加用丹参川芎嗪注射液。根据显效率对比两组的疗效。结果:两组患者一般资料无显著性差异,观察组显效率优于对照组且有显著性差异。结论:临床应用丹参川芎嗪注射液联合脑苷肌肽注射液治疗急性缺血性脑卒中具有较好疗效,优于单用脑苷肌肽注射液,是较好的药物组合。
Objective: To analyze the clinical effect of ligustrazine injection combined with cerebroside in the treatment of acute ischemic stroke. Methods: Sixty hospitalized patients with acute ischemic stroke were randomly divided into control group and observation group, with 30 cases in each group. The patients in each group were given routine treatment plus CGM injection and the control group with the injection of Danshen Ligustrazine liquid. According to the markedly efficient comparison of the two groups. Results: There was no significant difference in the general data between the two groups. The observation group had better efficiency than the control group and had significant difference. Conclusion: The clinical application of Ligustrazine and Injection of Scutellarin in the treatment of acute ischemic stroke has better curative effect than that of single injection of encephalitoside, which is a good drug combination.